Background Bacterial vaginosis affects 15 to 50% of women of reproductive age, and
recurrence is common after treatment with an antibiotic agent. The high incidence of recurrence …

Background: Bacterial vaginosis (BV) is a common vaginal infection caused by a lack of
endogenous lactobacilli and overgrowth of pathogens that frequently recurs following antibiotic …

The development of non-hormonal contraceptives is critical to increase options for women.
In combination with prevention against sexually transmitted infections, they can become an …

Objective To validate anecdotal reports that abortion‐related complications decreased in
the Dominican Republic after the introduction of misoprostol into the country. Design …

Multipurpose prevention technologies (MPTs) represent a powerful opportunity to address
the unmet sexual and reproductive health needs of women in at-risk populations around the …

Objective: Multipurpose prevention technologies (MPTs) are an innovative class of products
that deliver varied combinations of human immunodeficiency virus (HIV) prevention, other …

Background Bacterial vaginosis might increase HIV risk by eliciting genital inflammation
and epithelial barrier disruption, whereas vaginal Lactobacillus crispatus is associated with …

Background Bacterial vaginosis (BV) causes genital inflammation and increases HIV risk,
whereas a vaginal microbiota dominated by Lactobacillus species is associated with immune …

Objective: Several fastidious bacteria have been associated with bacterial vaginosis (BV),
but their role in lactobacilli recolonization failure is unknown. We studied the effect of 7 BV-…

Background: Although physicians are expected to provide dietary counseling for patients
with cardiovascular (CV) risk factors such as hypertension, hyperlipidemia, diabetes, and …